<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1.0"><title>Insulin Guide — SugarWise</title><link rel="stylesheet" href="styles.css"></head><body>
<nav class="navbar"><div class="navbar-inner"><a class="brand" href="index.html">SugarWise</a><a class="home-link" href="index.html">All Topics</a></div></nav>
<div class="container">
<div class="page-header"><h1>Insulin Guide</h1><p>Types of insulin, injection technique, dosing strategies, storage, delivery devices, and practical tips</p></div>

<div class="danger"><strong>CRITICAL SAFETY NOTICE:</strong> Never start, stop, or change any medication or dosage without consulting your doctor. The drug information below is for educational awareness only. Individual dosing depends on your specific condition, kidney function, other medications, and medical history. Self-medication can be life-threatening.</div>

<div class="illus">
<svg width="300" height="110" viewBox="0 0 300 110" xmlns="http://www.w3.org/2000/svg">
<!-- Insulin pen -->
<rect x="40" y="40" width="140" height="20" rx="5" fill="#1a7a5a"/>
<rect x="40" y="40" width="45" height="20" rx="5 0 0 5" fill="#145e45"/>
<rect x="180" y="46" width="30" height="8" rx="2" fill="#64748b"/>
<rect x="210" y="48" width="15" height="4" rx="1" fill="#999"/>
<!-- Dose window -->
<rect x="100" y="44" width="20" height="12" rx="2" fill="white" stroke="#145e45" stroke-width="1"/>
<text x="110" y="54" text-anchor="middle" font-size="8" fill="#145e45" font-weight="700">12u</text>
<!-- Insulin drop animation -->
<circle cx="228" cy="52" r="3" fill="#1a7a5a">
  <animate attributeName="cy" values="52;70;52" dur="2s" repeatCount="indefinite"/>
  <animate attributeName="opacity" values="1;0;1" dur="2s" repeatCount="indefinite"/>
</circle>
<!-- Action profile curve -->
<text x="150" y="95" text-anchor="middle" font-size="9" fill="#64748b">Insulin Pen &amp; Delivery</text>
</svg>
</div>

<div class="section">
<h2><span class="icon-sm">&#x2753;</span> Why Insulin?</h2>
<p>Insulin is a life-saving hormone that is absolutely essential for people with Type 1 diabetes and is frequently needed by people with Type 2 diabetes as the disease progresses. Insulin therapy is indicated in the following situations:</p>
<ul>
<li><strong>All patients with Type 1 diabetes</strong> — from the time of diagnosis, lifelong.</li>
<li><strong>Type 2 diabetes</strong> when oral/non-insulin medications cannot achieve glycemic targets.</li>
<li><strong>Type 2 diabetes at diagnosis</strong> if HbA1c is very high (&ge; 10%) or the patient is symptomatic (polyuria, polydipsia, weight loss).</li>
<li><strong>Gestational diabetes</strong> when diet and exercise are insufficient.</li>
<li><strong>Hospitalized patients</strong> with hyperglycemia (insulin is the preferred inpatient glucose-lowering therapy).</li>
<li><strong>During acute illness, surgery, or DKA/HHS</strong> — insulin is required for metabolic stabilization.</li>
</ul>

<div class="note">
<strong>Important:</strong> Needing insulin is NOT a personal failure. In T2D, it reflects the natural decline in beta-cell function over time. Starting insulin when needed leads to better outcomes and should not be delayed due to fear or stigma.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F489;</span> Types of Insulin</h2>

<div class="info-cards">
<div class="info-card"><span class="ic-icon">&#x26A1;</span><div class="ic-title">Rapid-Acting</div><div class="ic-text">Onset 10-20 min &bull; Peak 1-3 h &bull; Mealtime bolus</div></div>
<div class="info-card"><span class="ic-icon">&#x1F551;</span><div class="ic-title">Long-Acting</div><div class="ic-text">Onset 1-2 h &bull; Flat profile &bull; Once daily basal</div></div>
<div class="info-card"><span class="ic-icon">&#x1F31F;</span><div class="ic-title">Ultra-Long</div><div class="ic-text">Degludec &bull; 42+ h duration &bull; Flexible timing</div></div>
<div class="info-card"><span class="ic-icon">&#x1F500;</span><div class="ic-title">Premixed</div><div class="ic-text">Basal + bolus combined &bull; Simplified regimens</div></div>
</div>

<div class="table-wrap">
<table>
<thead>
<tr><th>Category</th><th>Examples</th><th>Onset</th><th>Peak</th><th>Duration</th><th>Typical Use</th></tr>
</thead>
<tbody>
<tr><td><strong>Rapid-Acting</strong></td><td>Lispro (Humalog), Aspart (NovoRapid/NovoLog), Glulisine (Apidra)</td><td>10–20 min</td><td>1–3 hours</td><td>3–5 hours</td><td>Bolus (mealtime) insulin; correction doses</td></tr>
<tr><td><strong>Ultra-Rapid-Acting</strong></td><td>Faster aspart (Fiasp), Lispro-aabc (Lyumjev)</td><td>2–5 min</td><td>0.5–2 hours</td><td>3–5 hours</td><td>Bolus insulin; slightly faster onset than standard rapid</td></tr>
<tr><td><strong>Short-Acting (Regular)</strong></td><td>Regular insulin (Humulin R, Novolin R)</td><td>30–60 min</td><td>2–4 hours</td><td>6–8 hours</td><td>Mealtime (if rapid unavailable); IV use in hospitals</td></tr>
<tr><td><strong>Intermediate-Acting</strong></td><td>NPH (Humulin N, Novolin N)</td><td>1–3 hours</td><td>4–12 hours</td><td>12–18 hours</td><td>Basal coverage (twice daily); often in premixed formulations</td></tr>
<tr><td><strong>Long-Acting</strong></td><td>Glargine U100 (Lantus, Basaglar), Glargine U300 (Toujeo), Detemir (Levemir)</td><td>1–2 hours</td><td>Minimal/flat</td><td>20–24+ hours</td><td>Basal insulin (once or twice daily)</td></tr>
<tr><td><strong>Ultra-Long-Acting</strong></td><td>Degludec (Tresiba)</td><td>1–2 hours</td><td>Flat (no peak)</td><td>42+ hours</td><td>Basal insulin (once daily); very stable; flexible timing</td></tr>
<tr><td><strong>Premixed</strong></td><td>70/30 (NPH/Regular), 75/25 (Lispro mix), 50/50, Ryzodeg (Degludec/Aspart)</td><td>Varies</td><td>Dual peaks</td><td>Varies</td><td>Simplified regimens; covers basal + mealtime needs</td></tr>
</tbody>
</table>
</div>

<h3>Insulin Action Profiles — Timeline</h3>
<div class="timeline">
<div class="timeline-item"><div class="timeline-title">Ultra-Rapid (Fiasp, Lyumjev)</div><div class="timeline-text">Onset 2-5 min | Peak 0.5-2 h | Duration 3-5 h</div></div>
<div class="timeline-item"><div class="timeline-title">Rapid-Acting (Lispro, Aspart)</div><div class="timeline-text">Onset 10-20 min | Peak 1-3 h | Duration 3-5 h</div></div>
<div class="timeline-item"><div class="timeline-title">Short-Acting (Regular)</div><div class="timeline-text">Onset 30-60 min | Peak 2-4 h | Duration 6-8 h</div></div>
<div class="timeline-item"><div class="timeline-title">Long-Acting (Glargine, Detemir)</div><div class="timeline-text">Onset 1-2 h | Minimal peak | Duration 20-24+ h</div></div>
<div class="timeline-item"><div class="timeline-title">Ultra-Long (Degludec)</div><div class="timeline-text">Onset 1-2 h | Flat — no peak | Duration 42+ h</div></div>
</div>

<div class="tip">
<strong>Concentration Matters:</strong> Most insulin is U-100 (100 units/mL). Concentrated insulins include: U-200 (Tresiba), U-300 (Toujeo), and U-500 (Humulin R U-500 for severely insulin-resistant patients). Always verify the concentration to avoid dosing errors.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x2696;&#xFE0F;</span> Basal-Bolus Concept</h2>
<p>The basal-bolus regimen is considered the gold standard for insulin therapy, as it most closely mimics the body's natural insulin secretion pattern:</p>

<h3>Basal Insulin</h3>
<ul>
<li>Provides a low, steady level of insulin throughout the day and night.</li>
<li>Controls glucose between meals and during sleep.</li>
<li>Suppresses hepatic glucose production.</li>
<li>Typically: one injection of long-acting (glargine, degludec) or two injections of intermediate-acting (NPH).</li>
<li>Accounts for approximately <strong>40–50%</strong> of total daily insulin dose.</li>
</ul>

<h3>Bolus (Mealtime) Insulin</h3>
<ul>
<li>Rapid-acting insulin taken before each meal to cover the glucose rise from carbohydrates.</li>
<li>Dose is based on <strong>carbohydrate counting</strong>: an insulin-to-carb ratio (ICR) tells you how many grams of carbs are covered by 1 unit of insulin (e.g., 1:10 means 1 unit per 10 grams of carbs).</li>
<li>A <strong>correction factor</strong> (also called insulin sensitivity factor or ISF) is used to correct above-target glucose: it tells you how much 1 unit of insulin will lower your glucose (e.g., 1:50 means 1 unit lowers glucose by 50 mg/dL).</li>
<li>Accounts for approximately <strong>50–60%</strong> of total daily insulin dose, divided across meals.</li>
</ul>

<h3>Bolus Dose Calculation Example</h3>
<p>Patient with ICR = 1:10 and ISF = 1:40, target glucose = 120 mg/dL:</p>
<ul>
<li>Pre-meal glucose: 200 mg/dL</li>
<li>Planned carb intake: 60 grams</li>
<li>Carb dose: 60 / 10 = <strong>6 units</strong></li>
<li>Correction dose: (200 - 120) / 40 = <strong>2 units</strong></li>
<li>Total bolus: 6 + 2 = <strong>8 units</strong></li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F680;</span> Starting Insulin — Common Approaches</h2>

<h3>For Type 2 Diabetes (Adding Basal Insulin to Oral Therapy)</h3>
<ul>
<li><strong>Starting dose:</strong> 10 units/day OR 0.1–0.2 units/kg/day of long-acting insulin, taken at the same time each day (usually bedtime or morning).</li>
<li><strong>Titration:</strong> Adjust by 2–4 units every 3–7 days based on fasting glucose readings. Target fasting glucose: 80–130 mg/dL.</li>
<li><strong>Continue oral medications</strong> (metformin, SGLT2i, GLP-1 RA) alongside basal insulin. Sulfonylureas may be reduced or stopped when mealtime insulin is added.</li>
</ul>

<h3>For Type 1 Diabetes (Full Basal-Bolus)</h3>
<ul>
<li><strong>Total daily dose (TDD):</strong> Typically 0.4–0.6 units/kg/day initially (higher in puberty, lower in honeymoon phase).</li>
<li>50% as basal, 50% divided among meals as bolus.</li>
<li>ICR and ISF are adjusted based on glucose monitoring data.</li>
</ul>

<h3>Sliding Scale Insulin</h3>
<p>A sliding scale provides correction-only rapid-acting insulin based on pre-meal glucose readings. While still used in hospital settings, it is a reactive approach and is <strong>not recommended as a standalone outpatient regimen</strong>. It does not address basal insulin needs or anticipate carbohydrate intake.</p>

<div class="table-wrap">
<table>
<thead>
<tr><th>Blood Glucose (mg/dL)</th><th>Low-Dose Scale</th><th>Medium-Dose Scale</th><th>High-Dose Scale</th></tr>
</thead>
<tbody>
<tr><td>150–200</td><td>1 unit</td><td>2 units</td><td>4 units</td></tr>
<tr><td>201–250</td><td>2 units</td><td>4 units</td><td>7 units</td></tr>
<tr><td>251–300</td><td>3 units</td><td>6 units</td><td>10 units</td></tr>
<tr><td>301–350</td><td>4 units</td><td>8 units</td><td>13 units</td></tr>
<tr><td>&gt; 350</td><td>5 units</td><td>10 units</td><td>16 units</td></tr>
</tbody>
</table>
</div>

<div class="warning">
<strong>Warning:</strong> Sliding scale insulin alone leads to poor glycemic control — it treats hyperglycemia after it has already occurred rather than preventing it. It should always be combined with scheduled basal (and ideally bolus) insulin.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F4CD;</span> Injection Sites and Rotation</h2>

<h3>Recommended Injection Sites</h3>
<ul>
<li><strong>Abdomen:</strong> Fastest absorption. Preferred for rapid-acting (mealtime) insulin. Avoid a 2-inch radius around the navel.</li>
<li><strong>Thighs:</strong> Outer upper thighs. Slower absorption than abdomen. Good for long-acting insulin.</li>
<li><strong>Upper arms:</strong> Back/outer area. Moderate absorption. May need help reaching.</li>
<li><strong>Buttocks:</strong> Upper outer quadrant. Slowest absorption. Alternative site.</li>
</ul>

<h3>Site Rotation</h3>
<ul>
<li>Rotate injection sites systematically within the same anatomical area to prevent <strong>lipohypertrophy</strong> (lumpy, thickened tissue from repeated injections in the same spot).</li>
<li>Space injections at least 1–2 cm (one finger-width) apart within the same area.</li>
<li>Use the same general area at the same time of day for consistent absorption (e.g., always use the abdomen for breakfast bolus).</li>
<li>Inspect injection sites regularly for lumps, hardness, or skin changes.</li>
</ul>

<div class="warning">
<strong>Lipohypertrophy:</strong> Injecting repeatedly into the same spot causes fatty lumps under the skin. Insulin absorbed from these areas is unpredictable — leading to unexplained glucose variability. If lipohypertrophy is present, avoid injecting into those areas and allow them to resolve over months. Always rotate sites.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F4A1;</span> Injection Technique</h2>
<ol>
<li>If using a new pen, attach a new pen needle (4 mm, 5 mm, or 6 mm for most patients — shorter needles are recommended to avoid intramuscular injection).</li>
<li>Prime the pen: dial 2 units and press the injection button with the needle pointing up until a drop appears at the tip. This ensures proper function and removes air.</li>
<li>Dial the prescribed dose.</li>
<li>Choose a clean injection site. No alcohol swab needed if the skin is clean.</li>
<li>Insert the needle at 90 degrees (for 4–5 mm needles, no skin pinch needed in most adults). For longer needles or very lean patients, pinch a fold of skin.</li>
<li>Press the injection button all the way down.</li>
<li><strong>Count to 10</strong> (or until the dose counter returns to zero) before withdrawing the needle — this ensures the full dose is delivered.</li>
<li>Withdraw the needle and dispose of it in a sharps container.</li>
</ol>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F4F1;</span> Insulin Delivery Devices</h2>

<h3>Insulin Pens</h3>
<ul>
<li><strong>Prefilled disposable pens:</strong> Come preloaded with insulin (e.g., Lantus SoloStar, FlexPen). Discard when empty.</li>
<li><strong>Reusable pens:</strong> Accept insulin cartridges. More economical long-term.</li>
<li><strong>Smart pens:</strong> (e.g., InPen, NovoPen 6) — track doses, timing, and can calculate boluses. Data syncs to smartphone apps.</li>
<li>Advantages: Convenient, portable, accurate dosing, less painful than syringes, discreet.</li>
</ul>

<h3>Insulin Syringes</h3>
<ul>
<li>Available in U-100 (standard) markings: 30-unit (0.3 mL), 50-unit (0.5 mL), and 100-unit (1 mL) sizes.</li>
<li>Choose the smallest syringe that accommodates your dose for most accurate measurement.</li>
<li>Still widely used where pens are unavailable or cost-prohibitive.</li>
<li>Allows mixing of certain insulins (e.g., NPH + Regular in the same syringe — draw clear/regular first, then cloudy/NPH).</li>
</ul>

<h3>Insulin Pumps (CSII — Continuous Subcutaneous Insulin Infusion)</h3>
<ul>
<li>Small computerized device that delivers rapid-acting insulin continuously through a subcutaneous cannula.</li>
<li><strong>Basal rate:</strong> Programmable hourly rates replace long-acting insulin.</li>
<li><strong>Bolus:</strong> User-initiated doses for meals and corrections, with built-in calculators.</li>
<li><strong>Hybrid closed-loop (HCL) systems:</strong> Pump + CGM that automatically adjusts basal rates based on glucose readings (e.g., Medtronic 780G, Tandem Control-IQ, Omnipod 5). These systems significantly increase time in range and reduce hypoglycemia.</li>
</ul>

<div class="table-wrap">
<table>
<thead>
<tr><th>Feature</th><th>Pen/Syringe</th><th>Insulin Pump</th></tr>
</thead>
<tbody>
<tr><td>Injections/insertions</td><td>4–6+ injections daily</td><td>Infusion set change every 2–3 days</td></tr>
<tr><td>Basal delivery</td><td>1–2 long-acting injections</td><td>Programmable hourly rates; can be suspended</td></tr>
<tr><td>Bolus flexibility</td><td>Standard injection</td><td>Extended/dual-wave boluses for high-fat meals</td></tr>
<tr><td>Cost</td><td>Lower</td><td>Higher (device + supplies)</td></tr>
<tr><td>Training required</td><td>Minimal</td><td>Extensive</td></tr>
<tr><td>Best for</td><td>All insulin users</td><td>T1D; T2D with variable schedules; pregnancy; frequent hypoglycemia</td></tr>
</tbody>
</table>
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x2744;&#xFE0F;</span> Insulin Storage</h2>
<ul>
<li><strong>Unopened insulin:</strong> Store in the refrigerator at 2–8&deg;C (36–46&deg;F). Do not freeze — frozen insulin is permanently damaged and must be discarded.</li>
<li><strong>In-use insulin (pen or vial):</strong> Can be kept at room temperature (below 25–30&deg;C / 77–86&deg;F) for up to <strong>28–56 days</strong> depending on the product (check the package insert). Room-temperature insulin is more comfortable to inject.</li>
<li><strong>Avoid:</strong> Direct sunlight, extreme heat (car glove compartment, windowsill), and freezing.</li>
<li><strong>When traveling:</strong> Carry insulin in a cool bag or insulated case. Never check insulin in airline luggage (cargo hold can freeze). Carry a prescription letter for security.</li>
<li><strong>Inspect before use:</strong> Clear insulins (rapid, long-acting) should be clear and colorless. Discard if cloudy, discolored, or contains particles. NPH should be uniformly cloudy after gentle mixing — discard if clumped or grainy.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F6A8;</span> Managing Hypoglycemia on Insulin</h2>
<p>Hypoglycemia (blood glucose &lt; 70 mg/dL) is the most common side effect of insulin therapy. It must be recognized and treated promptly.</p>

<h3>Symptoms</h3>
<ul>
<li><strong>Mild:</strong> Shakiness, sweating, hunger, rapid heartbeat, anxiety, pallor.</li>
<li><strong>Moderate:</strong> Confusion, difficulty concentrating, irritability, blurred vision, weakness.</li>
<li><strong>Severe:</strong> Loss of consciousness, seizures, inability to self-treat — requires assistance from another person.</li>
</ul>

<h3>Treatment — Rule of 15</h3>
<ol>
<li>Consume 15 grams of fast-acting glucose: 3–4 glucose tablets, 4 oz (120 mL) juice or regular soda, 1 tablespoon of honey or sugar.</li>
<li>Wait 15 minutes and recheck glucose.</li>
<li>If still &lt; 70 mg/dL, repeat step 1.</li>
<li>Once glucose normalizes, eat a snack or meal with protein and carbs to sustain levels.</li>
</ol>

<h3>Glucagon for Severe Hypoglycemia</h3>
<ul>
<li><strong>Glucagon injection kit:</strong> Requires reconstitution (mixing powder with diluent) and injection.</li>
<li><strong>Nasal glucagon (Baqsimi):</strong> Needle-free, single-dose nasal spray — easier to administer by bystanders.</li>
<li><strong>Ready-to-inject glucagon (Gvoke HypoPen):</strong> Pre-mixed, auto-injector — simple to use in emergencies.</li>
<li>All insulin users and their close contacts/family should have glucagon available and know how to use it.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F9D8;</span> Managing Injection Anxiety</h2>
<p>Fear of needles (trypanophobia) is common and can be a significant barrier to insulin initiation. Strategies to help:</p>
<ul>
<li><strong>Modern pen needles are tiny:</strong> 4 mm x 32G needles are shorter and thinner than most people imagine. The injection is usually less painful than a fingerstick.</li>
<li><strong>Numb the site:</strong> Apply an ice cube for 10–15 seconds before injecting, or use a topical anesthetic cream.</li>
<li><strong>Use a quick motion:</strong> Insert the needle confidently in one smooth motion — hesitation increases discomfort.</li>
<li><strong>Practice with saline:</strong> Healthcare providers can demonstrate with a saline injection so patients can experience the sensation without pressure.</li>
<li><strong>Injection aids:</strong> Spring-loaded devices (e.g., i-Port Advance) insert a small cannula that stays in place for 3 days — multiple injections go through the port without repeated skin punctures.</li>
<li><strong>Psychological support:</strong> For severe needle phobia, cognitive behavioral therapy (CBT) or guided exposure therapy can be effective.</li>
<li><strong>Consider alternatives:</strong> Insulin pumps (only one insertion every 2–3 days) or, for T2D patients not yet on insulin, injectable GLP-1 RAs with very fine needles.</li>
</ul>

<div class="tip">
<strong>Perspective:</strong> Most patients who were initially afraid of injections report that the anticipation was far worse than the reality. After a few days of practice, injections become routine and nearly painless.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x267B;&#xFE0F;</span> Safe Disposal of Sharps</h2>
<ul>
<li><strong>Used pen needles, syringes, and lancets</strong> are "sharps" and must be disposed of safely — never in regular household trash or recycling.</li>
<li>Place all sharps immediately after use in an <strong>FDA-cleared sharps container</strong> or a heavy-duty plastic container with a screw-on lid (e.g., a laundry detergent bottle). Label it "SHARPS — DO NOT RECYCLE."</li>
<li>When the container is three-quarters full, seal it and dispose of it according to local regulations:
<ul>
<li>Community sharps drop-off sites (pharmacies, hospitals, waste facilities)</li>
<li>Mail-back sharps disposal programs</li>
<li>Household hazardous waste collection events</li>
</ul>
</li>
<li><strong>Never:</strong> Clip, bend, or recap needles. Never flush sharps down the toilet. Never place loose sharps in recycling bins or trash bags.</li>
<li>When traveling, carry a portable sharps container and bring used sharps home for proper disposal.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F6AB;</span> Common Insulin Myths</h2>
<div class="table-wrap">
<table>
<thead>
<tr><th>Myth</th><th>Fact</th></tr>
</thead>
<tbody>
<tr><td>"Insulin means I've failed"</td><td>Insulin is needed because of progressive beta-cell decline, not personal failure. It is the most effective glucose-lowering therapy available.</td></tr>
<tr><td>"Insulin causes complications"</td><td>High blood glucose causes complications. Insulin helps prevent them by achieving better control.</td></tr>
<tr><td>"Once you start insulin, you can never stop"</td><td>In T1D, insulin is lifelong. In T2D, insulin may be reduced or stopped if significant weight loss, lifestyle changes, or other medications achieve targets.</td></tr>
<tr><td>"Insulin causes weight gain, so it must be bad"</td><td>Some weight gain may occur (better glucose utilization, reduced glycosuria), but the metabolic benefits of good control far outweigh this. Combining insulin with GLP-1 RA or SGLT2i can mitigate weight gain.</td></tr>
<tr><td>"Insulin injections are very painful"</td><td>Modern pen needles (4–5 mm, 32G) cause minimal discomfort — most patients describe it as a small pinch or less.</td></tr>
</tbody>
</table>
</div>
</div>

<div class="page-nav">
<a class="prev" href="medications-oral.html">Oral Medications</a>
<a class="next" href="latest-treatments.html">Latest Treatments</a>
</div>
</div>
<div class="disclaimer">This content is for educational purposes only and does not replace professional medical advice. The creators of SugarWise are not medical professionals. Do not start, stop, or change any medication without consulting your doctor. In case of emergency, call 112 (India) or your local emergency number. <a href="terms-of-use.html">Read full Terms of Use &amp; Medical Disclaimer</a></div>
<div class="footer">SugarWise &bull; Comprehensive Diabetes Management Companion &bull; <a href="terms-of-use.html">Terms of Use</a> &bull; Last updated: January 2026</div>
<button class="scroll-top" id="scrollTop" title="Back to top">&uarr;</button>
<script>
var sb=document.getElementById('scrollTop');window.addEventListener('scroll',function(){sb.classList.toggle('visible',window.scrollY>400)});sb.addEventListener('click',function(){window.scrollTo({top:0,behavior:'smooth'})});
document.querySelectorAll('.accordion-header').forEach(function(h){h.addEventListener('click',function(){this.parentElement.classList.toggle('open')})});
</script>
</body></html>